Clinical trial · Observational
Economic Analysis of Robotic Rectal Resection in German Health Care System
NCT06113796CI-TRIAL-00071029completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Analysis of cost effectiveness of robotic rectal resection, either sphincter preserving or abdominoperineal extirpation, in the German diagnosis related groups (DRG) system.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Rectal Cancer | Malignant Rectal Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Surgery | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Robotic sphincter-preserving rectal resection
- description
- Patients with robotic anterior or low anterior rectal resection and primary anastomosis for rectal cancer.
- interventionNames
- Other: Surgery
- label
- Robotic abdominoperineal rectal resection
- description
- Patients with robotic abdominoperineal rectal resection for rectal cancer.
- interventionNames
- Other: Surgery
Primary outcomes (1)
- measure
- Costs of treatment
- timeFrame
- 1 year
- description
- costs caused by the case
Secondary outcomes (3)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * 18y * histologically proven rectal cancer with curative therapeutic approach * suitable for minimally-invasive surgery Exclusion Criteria: * no rectal cancer * primary open surgery
References
Publications (0)
Data not yet available
No reference posted for this study.